Literature DB >> 29492832

Current status and progress of lymphoma research in East Asian countries: Introduction and planning.

Junji Suzumiya1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29492832     DOI： 10.1007/s12185-018-2425-3

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  9 in total

1.  Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.

Authors:  Seok Jin Kim; Kihyun Kim; Byung Soo Kim; Chul Yong Kim; Cheolwon Suh; Jooryung Huh; Sang-Wook Lee; Jin Seok Kim; Jaeho Cho; Gyeong-Won Lee; Ki Mun Kang; Hyeon Seok Eom; Hong Ryull Pyo; Yong Chan Ahn; Young Hyeh Ko; Won Seog Kim
Journal:  J Clin Oncol       Date:  2009-11-02       Impact factor: 44.544

2.  PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma.

Authors:  Hiroaki Miyoshi; Junichi Kiyasu; Takeharu Kato; Noriaki Yoshida; Joji Shimono; Shintaro Yokoyama; Hiroaki Taniguchi; Yuya Sasaki; Daisuke Kurita; Keisuke Kawamoto; Koji Kato; Yoshitaka Imaizumi; Masao Seto; Koichi Ohshima
Journal:  Blood       Date:  2016-07-14       Impact factor: 22.113

3.  Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma.

Authors:  Y Shi; M Dong; X Hong; W Zhang; J Feng; J Zhu; L Yu; X Ke; H Huang; Z Shen; Y Fan; W Li; X Zhao; J Qi; H Huang; D Zhou; Z Ning; X Lu
Journal:  Ann Oncol       Date:  2015-06-23       Impact factor: 32.976

4.  Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis.

Authors:  Seok Jin Kim; Joon Young Choi; Seung Hyup Hyun; Chang-Seok Ki; Dongryul Oh; Yong Chan Ahn; Young Hyeh Ko; Sunkyu Choi; Sin-Ho Jung; Pek-Lan Khong; Tiffany Tang; Xuexian Yan; Soon Thye Lim; Yok-Lam Kwong; Won Seog Kim
Journal:  Lancet Haematol       Date:  2015-01-28       Impact factor: 18.959

5.  Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification.

Authors:  Sun Och Yoon; Cheolwon Suh; Dae Ho Lee; Hyun-Sook Chi; Chan Jeoung Park; Seong-Soo Jang; Hai-Rim Shin; Bong-Hee Park; Jooryung Huh
Journal:  Am J Hematol       Date:  2010-10       Impact factor: 10.047

6.  Waldeyer's ring marginal zone B cell lymphoma: are the clinical and prognostic features nodal or extranodal? A study by the Consortium for Improving Survival of Lymphoma (CISL).

Authors:  Sung Yong Oh; Won Seog Kim; Jin Seok Kim; Seok Jin Kim; Suee Lee; Dae Ho Lee; Soon Il Lee; Hye Jin Kang; Chul Won Choi; Jinny Park; Moo Kon Song; Hyo Jung Kim; Jung Hye Kwon; Jae-Yong Kwak; Sung Hwa Bae; Byeong-Bae Park; Young-Rok Do; Ho Sup Lee; Seong Hyun Jeong; Cheolwon Suh; Hyo-Jin Kim
Journal:  Int J Hematol       Date:  2012-10-12       Impact factor: 2.490

7.  Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification.

Authors:  Jian Sun; Qunpei Yang; Zhaohui Lu; Miaoxia He; Li Gao; Minghua Zhu; Lu Sun; Lixin Wei; Min Li; Cuiling Liu; Jie Zheng; Weiping Liu; Gandi Li; Jie Chen
Journal:  Am J Clin Pathol       Date:  2012-09       Impact factor: 2.493

8.  Distribution of malignant lymphoma in Japan: analysis of 2260 cases, 2001-2006.

Authors:  Ryosuke Aoki; Kennosuke Karube; Yasuo Sugita; Yuko Nomura; Kay Shimizu; Yoshizo Kimura; Keiko Hashikawa; Nobuko Suefuji; Masahiro Kikuchi; Koichi Ohshima
Journal:  Pathol Int       Date:  2008-03       Impact factor: 2.534

9.  Differences in incidence and trends of haematological malignancies in Japan and the United States.

Authors:  Dai Chihara; Hidemi Ito; Tomohiro Matsuda; Akiko Shibata; Akira Katsumi; Shigeo Nakamura; Sobue Tomotaka; Lindsay M Morton; Dennis D Weisenburger; Keitaro Matsuo
Journal:  Br J Haematol       Date:  2013-11-18       Impact factor: 6.998
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.